SCHEMBL631704

SCHEMBL631704

Cc1cn(C)nc1C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
PTGER1 P34995 1/20 0.36
NPC1 O15118 1/20 0.36
NFKB1 P19838 1/20 0.36
RAB9A P51151 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.36
NOTUM Q6P988 1/20 0.35
MAPK1 P28482 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MAPT P10636 1/20 0.35
CASP3 P42574 1/20 0.35
KMT2A Q03164 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16559306 0.86 MAPK1 (0.36) KDM4EL3MBTL1NPC1NFKB1RAB9A
SCHEMBL18723264 0.83 LMNA (0.36) KDM4EL3MBTL1NPC1RAB9ALMNA
SCHEMBL13270673 0.82 MAPT (0.35) KDM4EL3MBTL1NPC1RAB9ALMNA
SCHEMBL2214484 0.81 LMNA (0.41) KDM4ENPC1RAB9ALMNATSHR
SCHEMBL3081863 0.81 ADORA2A (0.49) KDM4ERAB9ALMNAADORA2AADORA1
Hydrochloric Acid SCHEMBL4030867 0.79 ADORA2A (0.47) KDM4ERAB9ALMNAADORA2AADORA1
Hydrochloric Acid SCHEMBL4032485 0.79 ADORA2A (0.47) KDM4ERAB9ALMNAADORA2AADORA1
SCHEMBL2805806 0.78 L3MBTL1 (0.41) KDM4EL3MBTL1LMNATSHRNOTUM
SCHEMBL21233045 0.78 ADORA3 (0.37) KDM4EL3MBTL1NPC1RAB9ALMNA
SCHEMBL3676954 0.78 NPC1 (0.47) KDM4EL3MBTL1PTGER1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 492 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108117520-A A kind of 1,3- dimethyl -1H- pyrazoles -4- amide derivatives and preparation method and application 浙江工业大学 2018-06-05 CN claimed
US-20260132132-A1 3A,4,5,6-TETRAHYDRO-1 H-PYRAZOLO[3,4-C]PYRIDIN-7(7AH)-ONE DERIVATIVES AS FACTOR XIIA INHIBITORS KALVISTA PHARMACEUTICALS LTD (GB) 2026-05-14 US disclosed
EP-3867248-B1 PYRAZOLE DERIVATIVES AS H4 ANTAGONIST COMPOUNDS NXERA PHARMA UK LTD (GB) 2025-12-10 EP disclosed
US-12398120-B2 Substituted hydantoinamides as ADAMTS7 antagonists BAYER AKTIENGESELLSCHAFT (DE) 2025-08-26 US disclosed
US-12359118-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2025-07-15 US disclosed
US-12336426-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2025-06-17 US disclosed
CN-120077042-A 3A,4,5, 6-tetrahydro-1H-pyrazolo [3,4-C ] pyridin-7 (7 AH) -one derivatives as factor XIIa inhibitors 卡尔维斯塔制药有限公司 2025-05-30 CN disclosed
US-20250169360-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2025-05-22 US disclosed
WO-2025096653-A1 COMPOSITIONS AND INHIBITORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed
WO-2025096657-A1 COMPOSITIONS AND INHIBITORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed
CN-101171256-A Fused thiazole derivatives having affinity for the histamine h3 receptor GLAXO GROUP LTD (GB) 2008-04-30 CN disclosed
WO-2008016192-A2 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-02-07 WO disclosed
WO-2008016192-A2 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-02-07 WO disclosed
CN-1659168-A Amide-substituted xanthine derivatives having gluconeogenesis modulating activity HOFFMANN LA ROCHE (CH) 2005-08-24 CN disclosed
EP-1556032-A1 AGENT FOR PREVENTING OR TREATING NEUROPATHY Takeda Pharmaceutical Company Limited (JP) 2005-07-27 EP disclosed
WO-2004039365-A1 AGENT FOR PREVENTING OR TREATING NEUROPATHY TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-05-13 WO disclosed
EP-0695748-B1 Tetrazolinone herbicides BAYER AGROCHEM KK (JP) 1999-05-06 EP disclosed
US-5589439-A HERBICIDES NIHON BAYER AGROCHEM K.K. (JP) 1996-12-31 US disclosed
CN-1122333-A Tetrazolinone derivatives BAYER AGROCHEM KK (JP) 1996-05-15 CN disclosed
EP-0695748-A1 Tetrazolinone herbicides NIHON BAYER AGROCHEM K.K. (JP) 1996-02-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132132-A1 3A,4,5,6-TETRAHYDRO-1 H-PYRAZOLO[3,4-C]PYRIDIN-7(7AH)-ONE DERIVATIVES AS FACTOR XIIA INHIBITORS F11, F13B, F7 KDM4E 2529/4885L3MBTL1 3267/4885PTGER1 379/4885
US-20250169360-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, ITGB4, OCIAD2 KDM4E 2398/4885L3MBTL1 4430/4885PTGER1 2971/4885
US-12398120-B2 Substituted hydantoinamides as ADAMTS7 antagonists ADAMTS7, MMP7, ADAM17 KDM4E 3062/4885L3MBTL1 2418/4885PTGER1 1891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.